
BACKGROUND: Antibiotic resistance remains a common challenge in treatment of infectious diseases, including ocular ones. Resistance of ocular pathogens can hinder choosing an antimicrobial agent and reduce the effectiveness of prescribed antibacterial therapy. Therefore, constant monitoring of pathogen susceptibility is an important step in tackling increasing antibiotic resistance. AIM: This study aimed to identify causative agents of bacterial infections of the eyelid and conjunctiva and analyze their susceptibility to antibacterial agents in patients aged over 3 years. METHODS: We analyzed the data of 20,607 conjunctival microbiome tests in patients with bacterial infections of the eyelid and conjunctiva who visited an outpatient department of the St. Petersburg Diagnostic Center No. 7 in 2018–2024. Conjunctival swabs were taken from all patients to identify pathogens and determine their antimicrobial susceptibility. Microorganisms were isolated and identified by microscopic, cultural, and biochemical methods. RESULTS: Bacterial infections of the anterior segment were caused by Gram-positive microorganisms in 46% of cases, mainly by Staphylococcus epidermidis with a detection rate of 32.5%–37.9%, followed by Gram-negative microorganisms identified in 34% of cases, of which Klebsiella pneumoniae was the most common with a detection rate of 16%–23.5%. Mixed Gram-positive and Gram-negative flora was identified in the remaining 20% of cases. Data analysis revealed high resistance of all pathogens to azithromycin, with S. epidermidis resistance of up to 64%. All isolated pathogens were most susceptible (up to 99%) to fourth-generation fluoroquinolones, namely to moxifloxacin. CONCLUSION: Based on the data obtained, moxifloxacin products may be recommended for ophthalmological use as an agent of choice for the treatment of bacterial infections of the eyelids and conjunctiva.
BACKGROUND: Published data show that one third of patients who underwent urgent keratoplasty experience graft melting, resulting in repeated corneal transplantation. However, no dedicated studies have been conducted to determine causes of keratolysis and ways to address them in patients with urgent corneal disorder. AIM: The study aimed to evaluate the effectiveness of platelet-rich plasma lysate in urgent corneal transplantation in patients with keratolysis based on the data of a comprehensive clinical immunoassay. METHODS: A comparative cohort study was conducted. A total of 50 patients with lysis of the cornea and corneal graft were examined. All patients underwent urgent keratoplasty. Patients were divided into two groups based on postoperative therapy. The first group included 30 patients receiving standard post-transplant therapy. The second group included 20 patients who additionally received subconjunctival injections and instillations of platelet-rich plasma lysate until the graft was completely epithelized. Whole blood samples were used for immunoassay. Phenotyping was performed by flow cytometry. RESULTS: Prior to keratoplasty, the following common characteristic changes were found in lymphocytes of patients with lysis of the cornea and corneal graft: an increase in absolute total CD3+ lymphocyte count; main regulatory T cell subpopulations, T helpers (CD3+CD4+); cytotoxic cells (CD3+CD8+), a minor subpopulation of double-positive T cells (CD3+CD4+CD8+), B lymphocytes (CD19+), and natural killer cells (CD16+CD56+) (p 0.05). Postoperatively, patients with poor keratoplasty outcome demonstrated a further increase in absolute lymphocyte and total T and B cell count and unchanged high count of natural killer cells. Favorable keratoplasty outcomes are explained by positive changes in the T cell subpopulations, which were most pronounced in the platelet-rich plasma group with a decrease in lymphocyte count (CD45+), including total CD3+ lymphocyte, T helper cell, and double-positive T lymphocyte count. CONCLUSION: Clinical observations suggest that addition of platelet-rich plasma lysate to therapy in patients after primary and repeat urgent transplantation was more effective than standard postoperative therapy. This is confirmed by corneal engraftment in all patients in the platelet-rich plasma lysate group compared with the standard therapy group, where a favorable outcome was reported in only one third of cases.
BACKGROUND: Thyroid eye disease is an independent progressive autoimmune eye condition involving the thyroid gland. Thyroid eye disease requires researches because of the high risk of visual impairment, and permanent vision loss develops with delayed treatment or therapy not based on activity and severity. The disease progresses to more severe forms in up to 15% of cases, leading to a decrease in visual function up to its complete loss. The article describes first combined medication therapy and assesses its effectiveness. AIM: The study aimed to assess the effectiveness of combined medication therapy, including glucocorticoid pulse therapy for active thyroid eye disease. METHODS: A total of 84 patients with active thyroid eye disease aged 26 to 75 years were treated and underwent comprehensive clinical ophthalmological examination and imagining before and after treatment. All patients received combined medication therapy, including high-dose glucocorticoid therapy, cyclophosphamide, and symptomatic and topical therapy. The mean follow-up was 86.2 ± 8.7 months. RESULTS: The treatment course effectiveness, including cyclophosphamide injections, was 94.6% with no clinically significant side effects. There were three cases of reactivation of thyroid eye disease caused by a recurrence of thyroid disease after 6 months CONCLUSION: Additional immunosuppressive agents and symptomatic therapy in the treatment strategy, along with high-dose glucocorticoids, increase the treatment effectiveness up to 96.4%, restore visual function, and provide sustained remission.
Late in-the-bag intraocular lens dislocation is a clinically significant complication of cataract surgery, which can develop years after initially successful phacoemulsification and lead to a marked decrease in visual function. Although various techniques of secondary intraocular lens (IOL) fixation are available, so far there is no universal minimally invasive approach ensuring high lens stability and a low risk of intraocular damage, especially in patients with no vitreous, zonular damage, and vitreoretinal history. Therefore, ophthalmic surgery requires new technical solutions to optimize posterior chamber IOL fixation in case of late dislocation. The article describes a clinical case of surgical treatment of a 66-year-old patient with late in-the-bag dislocation of a posterior chamber acrylic IOL into the vitreous 15 years after phacoemulsification. The patient had concomitant risk factors, including high myopia, previous vitrectomy for rhegmatogenous retinal detachment, and controlled open-angle glaucoma. IOL repositioning was performed followed by sutureless transoptical three-point non-collinear flanged fixation to the sclera and cornea. The technique involved suturing the periphery of the lens optic at three points to create multiple fixation vectors. In the postoperative period, uncorrected and best corrected visual acuity increased, and the IOL was stable and centered without any signs of tilt or decentration. Optical coherence tomography and ultrasound biomicroscopy confirmed correct anatomical lens position, no contact with the iris or cornea, and safe intracorneal position of the flanges. The presented clinical case demonstrates that three-point non-collinear transoptical flanged fixation can reliably stabilize the IOL in case of late dislocation and anatomical challenges. The conclusions are based on a single case and require further clinical confirmation in a larger patient population.
The Editor-in-Chief’s comment on the article by Yakushenko A.R., Potemkin V.V., Astakhov S.Yu., Babaeva Sh.E., Tobilko M.A., titled “First results of tunnel lateral canthoplasty in patients with involutional lower eyelid entropion” (2026;19(1):61–68, doi: https://doi.org/10.17816/OV686371) discusses aspects of ophthalmic plastic and reconstructive surgery—specifically, the fixation of the lateral canthus. The comment provides an evaluation of the manuscript and identifies the patient subgroup for whom the described surgical technique is likely to be most effective.